Dr. Ravi Teja Kodali, MD

Dr. Kodali practices at Nephrology Associates PA in Rock Hill, South Carolina.

Dr. Kodali's NPI, 1508275587, was assigned on August 4, 2014. Dr. Kodali holds Connecticut license 1.063652.

Dr. Kodali's primary practice is Nephrology Associates PA, at 1436 Riverchase Blvd, Rock Hill, SC 29732 in York County. The practice phone is (803) 329-2636.

Dr. Kodali's primary practice is Nephrology Associates PA in Rock Hill, South Carolina. Dr. Kodali is also affiliated with Rock Hill Hospital - Piedmont Medical Network. The medical group on file is Nephrology Associates. Dmand AI also links Dr. Kodali to 2 more hospitals, 1 dialysis center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kodali practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kodali's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Kodali's licenses on file in 2 states: Connecticut and Illinois.

CMS data shows 2,652 Medicare services from Dr. Kodali across 16 procedure codes in 2024, for 587 Medicare patients. Medicare paid $142,831 for them.

CMS counts 587 Medicare patients who saw Dr. Kodali in 2024. The largest group is 75 to 84, with 251 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 16% are also on Medicaid. Their average risk score is 2.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kodali's median patient age at 72, with 49% women.

In 2024, Dr. Kodali wrote 1,519 Medicare Part D claims for 266 patients. 92% of them were for generic drugs. CMS names the drug for 1,223 of them, across 27 drugs with 11 or more claims each, at $58,685 in total drug cost. In 2023, CMS named 777 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Kodali for performance year 2024, reported as part of a group. Dr. Kodali accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Kodali, published from 2020 to 2023. The most frequent topics are Acute Kidney Injury, COVID-19 and Renal Dialysis. Dr. Kodali's most frequent co-authors are Neera Kanhouwa Dahl, MD, Enver Akalin, MD and Abinet M. Aklilu, MD.

CMS Open Payments shows 22 general payments to Dr. Kodali from 15 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 68% of the total. Relypsa, Inc. paid the most, $200.